ZNF280A
gene geneOn this page
Also known as 3'OY11.1ZNF636
Summary
ZNF280A (zinc finger protein 280A, HGNC:18597) is a protein-coding gene on chromosome 22q11.22, encoding Zinc finger protein 280A (P59817). May function as a transcription factor.
This gene encodes a zinc finger protein. The encoded protein contains 4 C2H2-type zinc fingers, which are commonly found in transcription factors. A variety of functions may be performed by this type of zinc finger protein, including the binding of DNA or RNA.
Source: NCBI Gene 129025 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_080740
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18597 |
| Approved symbol | ZNF280A |
| Name | zinc finger protein 280A |
| Location | 22q11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | 3’OY11.1, ZNF636 |
| Ensembl gene | ENSG00000169548 |
| Ensembl biotype | protein_coding |
| Entrez | 129025 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000302097
RefSeq mRNA: 1 — MANE Select: NM_080740
NM_080740
CCDS: CCDS13800
Canonical transcript exons
ENST00000302097 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001135391 | 22513736 | 22515701 |
| ENSE00001256153 | 22520089 | 22520270 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 88.42.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4499 / max 68.3181, expressed in 155 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 193277 | 0.4499 | 155 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.42 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 64.64 | gold quality |
| left adrenal gland | UBERON:0001234 | 63.98 | gold quality |
| right adrenal gland | UBERON:0001233 | 62.83 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 62.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 62.06 | gold quality |
| adrenal gland | UBERON:0002369 | 59.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 41.19 | silver quality |
| placenta | UBERON:0001987 | 37.90 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| endometrium | UBERON:0001295 | 36.90 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| apex of heart | UBERON:0002098 | 35.38 | gold quality |
| sural nerve | UBERON:0015488 | 35.27 | gold quality |
| granulocyte | CL:0000094 | 34.92 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| vermiform appendix | UBERON:0001154 | 32.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| urinary bladder | UBERON:0001255 | 31.70 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| leukocyte | CL:0000738 | 30.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.16 | gold quality |
| monocyte | CL:0000576 | 29.96 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.70 | gold quality |
| liver | UBERON:0002107 | 29.28 | gold quality |
| tonsil | UBERON:0002372 | 28.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting ZNF280A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-10393-3P | 99.72 | 66.56 | 961 |
| HSA-MIR-6801-5P | 99.72 | 66.50 | 981 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-1206 | 99.30 | 69.32 | 1016 |
| HSA-MIR-5001-3P | 98.91 | 67.28 | 1394 |
| HSA-MIR-5088-5P | 97.97 | 64.28 | 487 |
| HSA-MIR-6818-5P | 97.50 | 67.10 | 1167 |
| HSA-MIR-6726-5P | 95.97 | 63.72 | 841 |
| HSA-MIR-920 | 95.97 | 63.95 | 811 |
| HSA-MIR-4300 | 95.85 | 64.56 | 1003 |
| HSA-MIR-5591-5P | 95.85 | 64.76 | 1002 |
| HSA-MIR-6874-5P | 95.73 | 64.94 | 545 |
Literature-anchored findings (GeneRIF, showing 2)
- ZNF280A promotes lung adenocarcinoma development by regulating the expression of EIF3C. (PMID:33414445)
- Knockdown of ZNF280A inhibits cell proliferation and promotes cell apoptosis of bladder cancer. (PMID:37345848)
Cross-species orthologs
0 orthologs
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger protein 280A — P59817 (reviewed: P59817)
Alternative names: 3’OY11.1, Suppressor of hairy wing homolog 1, Zinc finger protein 636
All UniProt accessions (1): P59817
UniProt curated annotations — full annotation on UniProt →
Function. May function as a transcription factor.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_542778* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR025243 | DUF4195 | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF13836
UniProt features (20 total): sequence variant 9, zinc finger region 4, compositionally biased region 4, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59817-F1 | 60.84 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP, YAGI_AML_WITH_11Q23_REARRANGED, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, HES2_TARGET_GENES, LCORL_TARGET_GENES, SNRNP70_TARGET_GENES, MIR6801_5P, MIR10393_3P, GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP, GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
378 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF280A | POM121L1P | Q3SYA9 | 624 |
| ZNF280A | GGTLC2 | Q14390 | 621 |
| ZNF280A | ZNF200 | P98182 | 595 |
| ZNF280A | PRAME | P78395 | 582 |
| ZNF280A | IQANK1 | A8MXQ7 | 580 |
| ZNF280A | ZNF668 | Q96K58 | 565 |
| ZNF280A | ZNF382 | Q96SR6 | 511 |
| ZNF280A | OR1L3 | Q8NH93 | 506 |
| ZNF280A | ZNF84 | P51523 | 504 |
| ZNF280A | OR1L1 | Q8NH94 | 496 |
| ZNF280A | RIMBP3B | A6NNM3 | 446 |
| ZNF280A | CCDC71L | Q8N9Z2 | 446 |
| ZNF280A | ZNF285 | Q96NJ3 | 417 |
| ZNF280A | ZNF276 | Q8N554 | 407 |
| ZNF280A | HSFY1 | Q96LI6 | 402 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PDE4C | ZNF280A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280A | ENOPH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280A | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF280A | CABP5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280A | EIF1AD | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280A | PDE4C | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF280A | H2BC20P | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF280A | NUCB2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF280A | KDM1A | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF280A | NUCB2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF280A | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ENOPH1 | ZNF280A | psi-mi:“MI:0915”(physical association) | 0.000 |
| CABP5 | ZNF280A | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1AD | ZNF280A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (31): ZNF280B (Affinity Capture-MS), NUCB2 (Affinity Capture-MS), HDGFRP3 (Affinity Capture-MS), RBM42 (Affinity Capture-MS), UPF3B (Affinity Capture-MS), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), ZNF280A (Two-hybrid), EIF1AD (Two-hybrid), CALM1 (Two-hybrid), ZNF280A (Proximity Label-MS), NUCB2 (Affinity Capture-MS), ZNF280A (Proximity Label-MS)
ESM2 similar proteins: A0A0R4IYX6, A0A1D5NVS8, A0AVK6, A4QP16, A5GFT6, A7XYJ6, B8A5Y1, D4A666, E1B7L7, E1BKK0, F1LMN3, F1QLG5, F1QZ88, F6NSX9, F7EA39, O73590, P12757, P59817, Q0VEE6, Q2IBF7, Q2TB10, Q53TQ3, Q566I1, Q58FA4, Q5R431, Q5ZIX8, Q60665, Q63679, Q68FE9, Q69ZF8, Q6IQ32, Q6P2L6, Q6PCM1, Q6ZSZ6, Q6ZU65, Q7Z3K3, Q80WC1, Q86UP3, Q8BHZ4, Q8BZH4
Diamond homologs: P59817, Q5PPG4, Q68FE8, Q6N043, Q6P3Y5, Q7Z3K3, Q86YH2, Q8BZH4, Q8ND82, Q99KZ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
313 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:22520083:G:C | donor_gain | 1.0000 |
| 22:22520178:T:TA | donor_gain | 1.0000 |
| 22:22517774:T:C | donor_gain | 0.9900 |
| 22:22517778:AGAT:A | donor_gain | 0.9900 |
| 22:22520083:GCTCA:G | donor_loss | 0.9900 |
| 22:22520084:CTCAC:C | donor_loss | 0.9900 |
| 22:22520085:TCACC:T | donor_loss | 0.9900 |
| 22:22520086:CA:C | donor_loss | 0.9900 |
| 22:22520087:A:AC | donor_gain | 0.9900 |
| 22:22520087:A:AT | donor_loss | 0.9900 |
| 22:22520088:C:CC | donor_gain | 0.9900 |
| 22:22520088:C:T | donor_loss | 0.9900 |
| 22:22520093:T:TA | donor_gain | 0.9800 |
| 22:22520088:CCAG:C | donor_gain | 0.9600 |
| 22:22520087:AC:A | donor_gain | 0.9400 |
| 22:22520088:CC:C | donor_gain | 0.9400 |
| 22:22515702:C:A | acceptor_loss | 0.9100 |
| 22:22515703:T:G | acceptor_loss | 0.9100 |
| 22:22516501:C:A | donor_gain | 0.9000 |
| 22:22515704:A:C | acceptor_loss | 0.8800 |
| 22:22515710:A:T | acceptor_loss | 0.8800 |
| 22:22516493:TGC:T | donor_gain | 0.8800 |
| 22:22520082:AGCT:A | donor_gain | 0.8800 |
| 22:22520088:CCA:C | donor_gain | 0.8800 |
| 22:22520088:CCAGT:C | donor_gain | 0.8600 |
| 22:22515713:C:CT | acceptor_loss | 0.8500 |
| 22:22516527:C:CA | donor_gain | 0.8400 |
| 22:22515712:CCA:C | acceptor_loss | 0.7700 |
| 22:22515716:G:C | acceptor_loss | 0.7000 |
| 22:22520090:AGTT:A | donor_gain | 0.6900 |
AlphaMissense
3605 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000277935 (22:22519104 A>G), RS1000873439 (22:22517155 C>T), RS1001326753 (22:22517356 G>A), RS1001955195 (22:22515312 C>G), RS1002004419 (22:22521520 T>C), RS1002058209 (22:22521805 G>A), RS1002183698 (22:22520482 C>T), RS1002286186 (22:22515847 A>G), RS1003518844 (22:22520657 G>A,T), RS1004112042 (22:22516288 C>T), RS1004846375 (22:22513599 C>T), RS1005116407 (22:22514828 T>C,G), RS1005578997 (22:22513488 C>CG), RS1005786395 (22:22521456 C>T), RS1006076608 (22:22520451 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1468 | Metabolite levels | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010406 | triacylglycerol 48:3 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression, decreases methylation, increases expression | 8 |
| Benzo(a)pyrene | increases methylation, affects methylation, increases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| trichostatin A | decreases expression, increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment, decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| Quercetin | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.